Search
for
Sort by
Research 91–120 of 1000+
- How does covid-19 affect the skin?
- Skin Manifestations of Rheumatological Diseases
- 13. Wound Healing & Hair
- 4. Bullous/Mucous Membrane
- Navigating Rhupus Complexity
- Navigating Rhupus Complexity
- Dermatological history and examination
- 11 Managing haematologic manifestations in SLE
- Rash morphology as a predictor of COVID‐19 severity: A systematic review of the cutaneous manifestations of COVID‐19
- Skin amidst COVID ‐19 pandemic
- Mechanisms of autophagy and their implications in dermatological disorders
- CUTANEOUS SIDE-EFFECTS OF BETA-ADRENERGIC BLOCKERS
- Cutaneous toxicities of new targeted cancer therapies: must know for diagnosis, management, and patient-proxy empowerment
- SUSPECTED CUTANEOUS DRUG TOXICITY IN RHEUMATOID ARTHRITIS—AN EVALUATION
- Ban Tu Wan hepatotoxicity
- Management of Skin Toxicities in Cancer Treatment: An Australian/New Zealand Perspective
- The COVID-19 pandemic and its skin effects
- Risk of Autoimmune Skin Diseases Associated With Immune Checkpoint Inhibitors: A Pharmacovigilance Analysis Using the FAERS Database
- Case report: Acrodermatitis enteropathica result from a novel SLC39A4 gene mutation
- Spotlight commentary: Navigating the cutaneous side effects of chemotherapy
- Acquired immunogenicity of DNA after modification with malondialdehyde in patients with alopecia areata
- ULBP3: a marker for alopecia areata incognita
- Altered expression of intracellular Toll-like receptors in peripheral blood mononuclear cells from patients with alopecia areata
- Drug-Induced Skin, Nail and Hair Disorders
- Geriatric Dermatology: Overview
- 5. HIV, Fungal and Infectious Diseases
- Adverse Dermatologic Effects of Cardiovascular Drug Therapy: Part III
- Isoniazid-induced alopecia
- Fatal Toxic Epidermal Necrolysis Associated with Minoxidil
- A clinical case of a patient with mucocutaneous and musculoskeletal manifestations after COVID-19 vaccination